Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism
Yıl: 2019 Cilt: 28 Sayı: 1 Sayfa Aralığı: 30 - 33 Metin Dili: İngilizce DOI: 10.5152/turkjnephrol.2019.3137 İndeks Tarihi: 21-07-2020
Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism
Öz: Objective: We investigated the effect of active D vitamin therapy on echocardiographic examination results in hemodialysis patients with hyperparathyroidism.Materials and Methods: This prospective study involved 20 patients who undergoing HD for a total of 12 hours per weekat least 6 months. Patients with serum intact parathormone level (iPTH) ≥20.8 pmol/L, phosphorus level 3.5 - 5.5 mg/dL,calcium level <9.5 mg/dL included in this study. Before and after 6 months active vitamin D treatment, left ventricular massindex (LVMI) of all patients were investigated by echocardiography.Results: The mean age was 51.2±15.0 Ten patients were female and ten patients were male. The mean iPTH level in serumbefore and six months after active vitamin-D treatment were 35.97±16.41 and 24.92±13.28 pmol/L respectively (p<0.001).Before and six months after active vitamin- D treatment the mean LVMI were 294.40±103.2 gr/m2 and 250.40±101.44 gr/m2 respectively. LVMI was statistically significant decreased after six months treatment compared to before treatment(p<0.001).Conclusion: Increased serum iPTH levels in patients undergoing HD decrease with active vitamin-D treatment and thisresults in significant reduction in LVMI. Our results show that treatment of hyperparathyroidism plays an important role incorrecting LVH.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Causes of death. United States Renal Data System. Am J Kidney Dis 1998; 32: S81-88. [CrossRef]
- 2. London GM. Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 2003; 16: 85-94. [CrossRef]
- 3. London GM, Parfrey PS. Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther 1997; 4: 194-211. [CrossRef]
- 4. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36: 286-90. [CrossRef]
- 5. Amann K, Ritz E, Wiest G, Klaus G, Mall G. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 1994; 4: 1814-19.
- 6. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis; 35: 1226-37. [CrossRef]
- 7. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-201. [CrossRef]
- 8. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; (113): S1-130.
- 9. Bloembergen WE. Cardiac disease in chronic uremia: epidemiology. Adv Ren Replace Ther 1997; 4: 185-93. [CrossRef]
- 10. Levin A, Foley RN: Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 2000; 36: S24-S30. [CrossRef]
- 11. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47: 186-92. [CrossRef]
- 12. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-8.
- 13. Massry SG. Parathyroid hormone: a uremic toxin. Adv Exp Med Biol 1987; 223: 1-17. [CrossRef]
- 14. Wu J, Garami M, Cheng T, Gardner DG. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest 1996; 97: 1577-88. [CrossRef]
- 15. Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh JC, et al. Molecular mechanisms of vitamin D action. Calcif Tissue Int 2013; 92: 77-98. [CrossRef]
- 16. Gunta SS, Thadhani RI, Mak RH. The effect of vitamin D status on risk factors for cardiovascular disease. Nat Rev Nephrol 2013; 9: 337-47. [CrossRef]
- 17. Leifheit-Nestler M, Grosse Siemer R, Flasbart K, Richter B, Kirchhoff F, Ziegler WH, et al. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease. Nephrol Dial Transplant 2016; 31: 1088-99. [CrossRef]
- 18. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999; 33: 73-81. [CrossRef]
- 19. Drueke T, Fauchet M, Fleury J, Lesourd P, Toure Y, Le Pailleur C, et al. Effect of parathyroidectomy on left-ventricular function in haemodialysis patients. Lancet 1980; 1: 112-4. [CrossRef]
| APA | ATILGAN K, ergün i, Aylı M, Odabas A (2019). Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism. , 30 - 33. 10.5152/turkjnephrol.2019.3137 |
| Chicago | ATILGAN KADIR GOKHAN,ergün ihsan,Aylı Mehmet Deniz,Odabas Ali Rıza Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism. (2019): 30 - 33. 10.5152/turkjnephrol.2019.3137 |
| MLA | ATILGAN KADIR GOKHAN,ergün ihsan,Aylı Mehmet Deniz,Odabas Ali Rıza Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism. , 2019, ss.30 - 33. 10.5152/turkjnephrol.2019.3137 |
| AMA | ATILGAN K,ergün i,Aylı M,Odabas A Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism. . 2019; 30 - 33. 10.5152/turkjnephrol.2019.3137 |
| Vancouver | ATILGAN K,ergün i,Aylı M,Odabas A Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism. . 2019; 30 - 33. 10.5152/turkjnephrol.2019.3137 |
| IEEE | ATILGAN K,ergün i,Aylı M,Odabas A "Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism." , ss.30 - 33, 2019. 10.5152/turkjnephrol.2019.3137 |
| ISNAD | ATILGAN, KADIR GOKHAN vd. "Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism". (2019), 30-33. https://doi.org/10.5152/turkjnephrol.2019.3137 |
| APA | ATILGAN K, ergün i, Aylı M, Odabas A (2019). Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism. Turkish journal of nephrology (Online), 28(1), 30 - 33. 10.5152/turkjnephrol.2019.3137 |
| Chicago | ATILGAN KADIR GOKHAN,ergün ihsan,Aylı Mehmet Deniz,Odabas Ali Rıza Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism. Turkish journal of nephrology (Online) 28, no.1 (2019): 30 - 33. 10.5152/turkjnephrol.2019.3137 |
| MLA | ATILGAN KADIR GOKHAN,ergün ihsan,Aylı Mehmet Deniz,Odabas Ali Rıza Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism. Turkish journal of nephrology (Online), vol.28, no.1, 2019, ss.30 - 33. 10.5152/turkjnephrol.2019.3137 |
| AMA | ATILGAN K,ergün i,Aylı M,Odabas A Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism. Turkish journal of nephrology (Online). 2019; 28(1): 30 - 33. 10.5152/turkjnephrol.2019.3137 |
| Vancouver | ATILGAN K,ergün i,Aylı M,Odabas A Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism. Turkish journal of nephrology (Online). 2019; 28(1): 30 - 33. 10.5152/turkjnephrol.2019.3137 |
| IEEE | ATILGAN K,ergün i,Aylı M,Odabas A "Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism." Turkish journal of nephrology (Online), 28, ss.30 - 33, 2019. 10.5152/turkjnephrol.2019.3137 |
| ISNAD | ATILGAN, KADIR GOKHAN vd. "Effect of Intravenous Active Vitamin-D Treatment on the Left Ventricular Mass Index in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism". Turkish journal of nephrology (Online) 28/1 (2019), 30-33. https://doi.org/10.5152/turkjnephrol.2019.3137 |
